show episodes
 
Artwork

1
VH US

V H US, Dirk Marshall

Unsubscribe
Unsubscribe
Hàng tháng+
 
Each episode of 'V H US' features host Dirk Marshall having an in-depth talk with various guests about that week's cult film and what it is like to have the profession portrayed (sometimes very loosely) in the film. Dirk Marshall was raised in a mom and pop video store in a small town. Growing up amongst the illustrious backdrop of VHS Box art, he learned about the world from the works of William Friedkin, Frank Henenlotter, and Penelope Spheeris. Now on VH US he sits down with people who's ...
  continue reading
 
Artwork

1
Hooked On Startups

Matthew Sullivan - Founder of QuantmRE.com

Unsubscribe
Unsubscribe
Hàng tháng
 
I’m Matthew Sullivan, and this is Hooked on Startups, the show where I chat with some of the most talented, inspiring and successful entrepreneurs who talk about their real life stories, overcoming challenges and failures, and mastering success. Get ready for some of the best business tips, tricks and tactics and some frank, unscripted discussions.
  continue reading
 
Artwork

1
Restore Podcast

Florida Conference of Seventh-day Adventists

Unsubscribe
Unsubscribe
Hàng tháng
 
A podcast seeking to Restore the Vision, Restore the Mission, Restore the Church. Presented by Javier Diaz, North Region Pastoral Ministries Field Associate for Florida Conference of Seventh-day Adventists.
  continue reading
 
Loading …
show series
 
Synopsis:Step into the future of biotech as host Rahul Chaturvedi delves into an exclusive conversation with Fabrice Chouraqui, CEO of Cellarity, as he unveils the groundbreaking ways AI is revolutionizing drug discovery. Fabrice will take you behind the scenes of Cellarity’s trailblazing approach, revealing how their pioneering technology is accel…
  continue reading
 
Send us a Text Message - include e-mail or phone number in your message to receive a response. In episode 104, we have a great conversation with Ken Wetmore, senior pastor of WholeLife Church. He talks about his faith journey, call to ministry, and what it was like transitioning to WholeLife after Pastor Andy McDonald retired, having served the con…
  continue reading
 
Synopsis:Get ready for an insightful conversation as host Rahul Chaturvedi connects with John Alam, CEO of CervoMed, to uncover the revolutionary advancements transforming dementia treatment, with a spotlight on Dementia with Lewy Bodies (DLB). John shares his remarkable journey from practicing medicine to leading cutting-edge biotech innovations, …
  continue reading
 
Synopsis:Renée Aguiar-Lucander, CEO of Calliditas Therapeutics, appears on this insightful episode of Biotech 2050 with host Rahul Chaturvedi. Renée shares her unconventional journey from investment banking to biotech leadership, underscoring the crucial role of capital markets and regulatory strategies. The discussion explores the unique challenge…
  continue reading
 
Synopsis: In this engaging episode, host, Rahul Chaturvedi welcomes Marshall Fordyce, Founder and CEO of Vera Therapeutics, to discuss his transformative journey from physician to biotech entrepreneur. Marshall shares the story behind Vera Therapeutics' strategic pivot to focus on IG nephropathy and their development of atacicept, a promising B-cel…
  continue reading
 
Synopsis:Zandy Forbes, Founder, President, and CEO of MeiraGTx, joins host Rahul Chaturvedi in this compelling episode. Zandy shares her inspiring journey from academia, where she developed a deep interest in molecular biology and genetics, to her significant role in biotech investing, and eventually leading a groundbreaking gene therapy company. S…
  continue reading
 
Synopsis:Dive into this episode of Biotech 2050 where host Rahul Chaturvedi interviews Jeb Keiper, CEO of Nimbus Therapeutics. Discover Jeb's fascinating journey from MIT chemist to industry leader, and the unique strategies that have driven Nimbus's success. Jeb discusses the evolution of biotech financing, the importance of taking bold risks, and…
  continue reading
 
Synopsis:Sujal Patel, co-founder and CEO of Nautilus Biotechnology, discusses their innovative work in proteomics and its impact on drug development. Sujal shares his transition from tech to biotech, the formation of Nautilus with Parag Mallick, and their revolutionary approach using multi-affinity probes. The conversation highlights the importance…
  continue reading
 
Send us a Text Message - include e-mail or phone number in your message to receive a response. Dr. John Peckham is back for episode 103 to talk about his newest book, Why We Pray: Understanding Prayer in the Context of Cosmic Conflict. Be sure to pick up a copy of this book that will bless and challenge you. Show Notes/Links/Resources Book: Why We …
  continue reading
 
Find Wendy: https://x.com/DFWendi https://www.instagram.com/wfreeman2112/ Find Dirk: https://www.instagram.com/vhus_podcast/ https://x.com/VHUS_Podcast https://www.patreon.com/vhus https://vhuspodcast.threadless.comBởi wendi freeman, dirk marshall
  continue reading
 
Synopsis: In this episode of Biotech 2050, host Alok Tayi, CEO and co-founder of Vibe Bio, speaks with Dr. Bruce Leuchter, President and CEO of Neurvati Neuroscience. They discuss capital markets, neurology, psychiatry, and Neurvati's work in ultra-rare diseases. Dr. Leuchter shares his journey from clinical training to leadership at Neurvati. The …
  continue reading
 
Send us a Text Message - include e-mail or phone number in your message to receive a response. In episode 102, we chat with Raewyn Orlich, associate pastor for discipleship and nurture at La Sierra University Church. We talk about her faith journey, call to pastoral ministry, and her book, In Grandpa's Shoes: An Invitation to Intergenerational Disc…
  continue reading
 
Synopsis: In this episode of BioTech 2050, Ken Keller, President and CEO of Daiichi Sankyo, Inc. provides an in-depth look into the company's transformation from a cardiovascular-focused organization to a leader in oncology. He discusses the groundbreaking advancements in antibody-drug conjugates (ADCs), particularly highlighting the success of the…
  continue reading
 
Find Shawn: https://plasticrocketpop.com https://x.com/ShawnRobare https://x.com/CFCPod Find JL: (Nice try.) Find Dirk: https://letterboxd.com/dirkmarshall/ https://twitter.com/VHUS_Podcast https://www.patreon.com/vhus https://vhuspodcast.threadless.com Find Wordburglar: wordburglar.comBởi Shawn Robare, JL Watkins, Wordburglar, Dirk Marshall
  continue reading
 
Synopsis: In this episode of Biotech2050, Praveen Tipirneni, CEO of Morphic Therapeutics, shares insights on Morphic’s strategic IPO, the rising interest in autoimmune treatments, the journey of their alpha 4 beta 7 program, and maintaining a conservative yet opportunistic approach in biotech. He also discusses the importance of building a strong t…
  continue reading
 
Synopsis: In this episode of BioTech 2050, Robert Ang, CEO of Vor Bio, shares insights on the current state of cancer therapies and next-gen modalities. He discusses Vor Bio's work on shielded stem cell transplants and CAR T-cell therapies targeting hematologic malignancies like AML and MDS. Robert also talks about his experience serving on boards …
  continue reading
 
Send us a Text Message - include e-mail or phone number in your message to receive a response. For episode 101, we hear from Kevin Christenson, head of Hope Studios, the cinematic arm of Hope Channel International. He and his team are behind the recently released feature film, The Hopeful, which begins to tell the story of the Adventist Church. I k…
  continue reading
 
Synopsis: In this episode of Biotech2050, Vik Bajaj, Co-founder and CEO of Foresite Labs, delves into the convergence of tech and biotech, hyper-growth phases in biotech companies, changes in finance and capital markets, and lessons from global healthcare systems, particularly the UK. He highlights the transformative potential of technology in biot…
  continue reading
 
Synopsis: In this episode of Biotech2050, Dr. Ted Love, former CEO of Global Blood Therapeutics and Current Chairman of BIO, shares insights on sickle cell breakthroughs, transitioning from academia to research, navigating a tight funding environment, and protecting an innovative ecosystem to benefit patients.Biography:Dr. Ted Love is the chair of …
  continue reading
 
Send us a Text Message - include e-mail or phone number in your message to receive a response. On this, our 100th episode of the Restore Podcast, we welcome back Pastor Ivan Williams who was our guest on episode 2 back in March 2016. He returns to talk about his new role, leadership, mission, his faith journey, and more. Speaking on a personal note…
  continue reading
 
Find Patrick: https://twitter.com/alleywaykrew https://twitter.com/ChainsawsClaws Find us: https://twitter.com/VHUS_Podcast https://www.instagram.com/vhus_podcast/ https://www.patreon.com/vhusBởi Patrick Vicious, Patrick Bartlett, Dirk Marshall, Alelie Cheval, chainsaws and claws
  continue reading
 
Synopsis: In this episode of the Biotech 2050 podcast, host Rahul Chaturvedi engages in a thought-provoking conversation with Ray Stevens, a prominent figure in the biotech industry who co-founded Structure Therapeutics. Ray's extensive experience and pivotal role in advancing structure-based drug discovery make him a compelling guest for biotech e…
  continue reading
 
Synopsis: In this episode of Biotech2050, Scott Megaffin, CEO of Adiso Therapeutics, shares valuable insights on the challenges and opportunities in the biotech industry. His deep involvement in the pharmaceutical and biopharmaceutical sector has shaped his strategic approach to leadership and business management. Scott emphasizes the importance of…
  continue reading
 
Synopsis: In this episode of the Biotech2050 podcast, Dr. Mathai Mammen, CEO of FogPharma, shares valuable insights into the future trends of the biotech industry and the development of peptide-based therapeutics. Dr. Mammen's extensive career trajectory, from academia to leading pharmaceutical organizations, provides a comprehensive understanding …
  continue reading
 
Send us a Text Message - include e-mail or phone number in your message to receive a response. On episode 99, I talk with Rich Aguilera who has been a leader in children's ministry for many years, creating content of all kinds to bless kids and families that lead them to know Jesus. This conversation is for everyone regardless whether they are invo…
  continue reading
 
Find Carmelita: https://twitter.com/CarmelitaSays https://letterboxd.com/carmelitasays/ Find Sarah Marshall: marshallshautesauce.com https://www.instagram.com/spicymarshall/ Find Dirk and support the show: https://www.patreon.com/vhus https://vhuspodcast.threadless.com https://www.instagram.com/vhus_podcast/…
  continue reading
 
Synopsis: In the recent episode of Biotech2050, Ken Galbraith, CEO of Zymeworks, shares profound insights into the biotech industry, leadership, and the complexities of developing innovative treatments for challenging cancers. Galbraith's accidental entry into biotech in 1987, despite lacking prior experience, led to his pivotal role in establishin…
  continue reading
 
Find Scott: https://dailydead.com/listen-to-scott-drebit-discuss-his-new-book-a-cut-below-a-celebration-of-b-horror-movies-1950s-1980s-on-a-new-episode-of-corpse-club/ https://dailydead.com/author/scottdrebit/ Find Dirk: https://www.patreon.com/vhus https://twitter.com/VHUS_Podcast/status/1745513349339844843 https://vhuspodcast.threadless.com…
  continue reading
 
Synopsis: In this episode of Biotech2050, host Alok Tayi engages in a profound conversation with Craig Chambliss, CEO and co-founder of Neurellis, delving into their strategic advancements in precision therapies for CNS diseases. Chambliss shares his journey, highlighting his finance and accounting background and pivotal roles in pharmaceutical com…
  continue reading
 
Synopsis: On the Biotech2050 podcast, Tuyen Ong, CEO at Ring Therapeutics and CEO partner at flagship pioneering, shared his journey from a medical background to leading innovative gene therapy companies, highlighting the importance of cross-disciplinary expertise in driving biotech advancements. His insights into the gene therapy landscape and the…
  continue reading
 
Loading …

Hướng dẫn sử dụng nhanh